Plandai's Medical Marijuana Research Could Benefit From FDA Approval of Clinical Trials
November 26, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 26, 2013) - Plandaí Biotechnology (OTCQB: PLPL) timed its move into medical marijuana research perfectly. This month the U.S. Food and Drug Administration...
New Report Shows Plandai Biotechnology's Diabetes Research More Important Than Ever
November 19, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 19, 2013) - Late last week the International Diabetes Federation (IDF) released a report filled with some staggering statistics in the fight against diabetes....
Plandai Biotechnology's Move Into Medical Marijuana Research Gets Validation With New Study
November 14, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 14, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) and its subsidiary, Cannabis Biosciences, Inc., received a strong validation for their move into medical...
Plandai Biotechnology Enters Medical Marijuana Arena With Industry-Changing Technology
October 31, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 31, 2013) - Plandaí Biotechnolgy, Inc. (OTCQB: PLPL) announced this week that it has entered the medical marijuana industry with its new wholly-owned...
Plandai Biotechnology, Inc. to Enter Medical Marijuana Field With Phyto Cannabinoid Extract
October 30, 2013 09:00 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 30, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnology, Inc. Involved in Numerous Clinical Trials as Company Prepares Products for Market
October 03, 2013 09:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 3, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) has several clinical trials already underway, and a host of others scheduled to commence in the company...
Plandai Biotechnology, Inc. Enters Fourth Quarter Stronger Than Ever With Pheroid(TM) Technology
October 02, 2013 08:45 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 2, 2013) - Plandaí Biotechnology Inc. (OTCQB: PLPL) already has a technology in place that is allowing it to boast of higher bioavailability with its...
Plandai Biotechnology, Inc. Announces New Extract in Its Ongoing Fight Against Malaria
October 01, 2013 09:00 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 1, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnology, Inc. Executes Letter of Intent to Sell All Estimated 2014 Phytofare Limonoid Production
September 25, 2013 09:00 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 25, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness,...
Plandai Biotechnology, Inc. Announces Agreement With Oasix, Inc. to Distribute Phytofare Pheroid Topical Products
September 24, 2013 09:00 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 24, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness,...